RxDoctor Payments Data

Roy Gallinger, MD

Family Medicine · Sylva, NCNPI 1235101858

Payments from drug & device makers

$6,446in general payments, 2019–2025

Across 397 payments — averaging $16.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Amgen$703
  • Novo Nordisk$690
  • Pfizer$520
  • Boehringer Ingelheim$450
  • AbbVie$432
  • plus $3K from 27 others

What the payments were for

  • Food & beverage$6,446100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,446 in reported general payments places this provider in the 90th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$330,053
Medicare patients
632
Services billed
5,286

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin181$165,277
EliquisApixaban171$152,953
OzempicSemaglutide102$106,767
TrulicityDulaglutide76$85,924
XareltoRivaroxaban85$66,273
FarxigaDapagliflozin Propanediol102$65,076
Soliqua 100-33Insulin Glargine/Lixisenatide42$59,634
ArexvyRsvpref3 Antigen/As01e/Pf171$53,489
LinzessLinaclotide25$25,991
Victoza 3-PakLiraglutide26$24,660
Repatha SureclickEvolocumab42$24,514
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35$24,138
RybelsusSemaglutide24$22,428
ShingrixVaricella-Zoster Ge/As01b/Pf85$19,094
InvokanaCanagliflozin11$16,684

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$450$165,277181 claims
PfizerEliquis$520$152,953171 claims
Novo NordiskOzempic, Rybelsus$690$129,194126 claims
GSKArexvy, Trelegy Ellipta, Shingrix, Breo Ellipta, Anoro Ellipta$428$127,416345 claims
Lilly USA, LLCTrulicity$325$85,92476 claims
Johnson & JohnsonXarelto, Invokana$218$82,95696 claims
AstraZenecaFarxiga, Symbicort$1,034$76,500147 claims
Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus$262$63,86856 claims
AbbVieLinzess$432$25,99125 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Sylva

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →